Alphatec Holdings, which designs and manufactures products for the surgical treatment of spine disorders, priced its offering of 9.3 million shares at $9 on Friday morning. The pricing came at a 36% discount to the midpoint of the originally proposed $13 to $15 range and well below the revised $11 to $12 range. Deutsche Bank and First Albany were the lead underwriters on the deal. The stock is expected to begin trading on the NASDAQ under the ticker ATEC later today.
